Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 23534731)

1.

Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies.

Guo YZ, Pan L, Du CJ, Ren DQ, Xie XM.

Asian Pac J Cancer Prev. 2013;14(1):243-8.

2.

C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.

Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA, Stricker BH.

J Clin Oncol. 2006 Nov 20;24(33):5216-22.

3.

Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study.

Prizment AE, Folsom AR, Dreyfus J, Anderson KE, Visvanathan K, Joshu CE, Platz EA, Pankow JS.

Cancer Causes Control. 2013 Dec;24(12):2077-87. doi: 10.1007/s10552-013-0285-y. Epub 2013 Sep 14.

4.

Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis.

Heikkilä K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J, Ben-Shlomo Y, Ebrahim S, Lawlor DA.

Cancer Causes Control. 2009 Feb;20(1):15-26. doi: 10.1007/s10552-008-9212-z. Epub 2008 Aug 15.

PMID:
18704713
5.

C-reactive protein levels are not associated with increased risk for colorectal cancer in women.

Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM.

Ann Intern Med. 2005 Mar 15;142(6):425-32.

PMID:
15767620
6.

C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis.

Zhou B, Liu J, Wang ZM, Xi T.

PLoS One. 2012;7(8):e43075. doi: 10.1371/journal.pone.0043075. Epub 2012 Aug 17.

7.

C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.

Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA.

Int J Cancer. 2008 Sep 1;123(5):1133-40. doi: 10.1002/ijc.23606. Review.

PMID:
18528865
8.

Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis.

Han Y, Mao F, Wu Y, Fu X, Zhu X, Zhou S, Zhang W, Sun Q, Zhao Y.

Int J Biol Markers. 2011 Oct-Dec;26(4):209-15. doi: 10.5301/JBM.2011.8872. Review.

PMID:
22139643
9.

Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.

Prizment AE, Anderson KE, Visvanathan K, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):297-307. doi: 10.1158/1055-9965.EPI-10-1146. Epub 2011 Jan 7.

10.

C-reactive protein and the risk of incident colorectal cancer.

Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ.

JAMA. 2004 Feb 4;291(5):585-90.

PMID:
14762037
11.

Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.

Allin KH, Nordestgaard BG.

Crit Rev Clin Lab Sci. 2011 Jul-Aug;48(4):155-70. doi: 10.3109/10408363.2011.599831. Review.

PMID:
22035340
12.

C-reactive protein and the risk of cancer: a mendelian randomization study.

Allin KH, Nordestgaard BG, Zacho J, Tybjaerg-Hansen A, Bojesen SE.

J Natl Cancer Inst. 2010 Feb 3;102(3):202-6. doi: 10.1093/jnci/djp459. Epub 2010 Jan 7.

13.

Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis.

Wang X, Bao W, Liu J, Ouyang YY, Wang D, Rong S, Xiao X, Shan ZL, Zhang Y, Yao P, Liu LG.

Diabetes Care. 2013 Jan;36(1):166-75. doi: 10.2337/dc12-0702. Review.

14.

Association between sleep duration and cancer risk: a meta-analysis of prospective cohort studies.

Lu Y, Tian N, Yin J, Shi Y, Huang Z.

PLoS One. 2013 Sep 4;8(9):e74723. doi: 10.1371/journal.pone.0074723. eCollection 2013.

15.

Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.

Allin KH, Nordestgaard BG, Flyger H, Bojesen SE.

Breast Cancer Res. 2011 Jun 3;13(3):R55. doi: 10.1186/bcr2891.

16.

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC.

J Natl Cancer Inst. 2011 Jul 20;103(14):1112-22. doi: 10.1093/jnci/djr216. Epub 2011 Jun 17.

17.

Sleep duration and cancer risk: a systematic review and meta-analysis of prospective studies.

Zhao H, Yin JY, Yang WS, Qin Q, Li TT, Shi Y, Deng Q, Wei S, Liu L, Wang X, Nie SF.

Asian Pac J Cancer Prev. 2013;14(12):7509-15. Review.

18.

C-reactive protein concentrations and subsequent ovarian cancer risk.

McSorley MA, Alberg AJ, Allen DS, Allen NE, Brinton LA, Dorgan JF, Pollak M, Tao Y, Helzlsouer KJ.

Obstet Gynecol. 2007 Apr;109(4):933-41.

PMID:
17400857
19.

Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.

Hong T, Liu A, Cai D, Zhang Y, Hua D, Hang X, Wu X.

Cancer Invest. 2013 May;31(4):279-85. doi: 10.3109/07357907.2013.789898.

PMID:
23627410
20.

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.

Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A, Ulrich CM.

J Clin Oncol. 2009 Jul 20;27(21):3437-44. doi: 10.1200/JCO.2008.18.9068. Epub 2009 May 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk